184 related articles for article (PubMed ID: 33774154)
1. Antioxidants Improve Oxaliplatin-Induced Peripheral Neuropathy in Tumor-Bearing Mice Model: Role of Spinal Cord Oxidative Stress and Inflammation.
Agnes JP; Santos VWD; das Neves RN; Gonçalves RM; Delgobo M; Girardi CS; Lückemeyer DD; Ferreira MA; Macedo-Júnior SJ; Lopes SC; Spiller F; Gelain DP; Moreira JCF; Prediger RD; Ferreira J; Zanotto-Filho A
J Pain; 2021 Aug; 22(8):996-1013. PubMed ID: 33774154
[TBL] [Abstract][Full Text] [Related]
2. Anti-allodynic effect of Buja in a rat model of oxaliplatin-induced peripheral neuropathy via spinal astrocytes and pro-inflammatory cytokines suppression.
Jung Y; Lee JH; Kim W; Yoon SH; Kim SK
BMC Complement Altern Med; 2017 Jan; 17(1):48. PubMed ID: 28088201
[TBL] [Abstract][Full Text] [Related]
3. Rosmarinic Acid Mitigates Mitochondrial Dysfunction and Spinal Glial Activation in Oxaliplatin-induced Peripheral Neuropathy.
Areti A; Komirishetty P; Kalvala AK; Nellaiappan K; Kumar A
Mol Neurobiol; 2018 Sep; 55(9):7463-7475. PubMed ID: 29427084
[TBL] [Abstract][Full Text] [Related]
4. Advances in the Understanding of Oxaliplatin-Induced Peripheral Neuropathy in Mice: 7-Chloro-4-(Phenylselanyl) Quinoline as a Promising Therapeutic Agent.
Reis AS; Paltian JJ; Domingues WB; Novo DLR; Costa GP; Alves D; Campos VF; Mesko MF; Luchese C; Wilhelm EA
Mol Neurobiol; 2020 Dec; 57(12):5219-5234. PubMed ID: 32869182
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol exerts anti-oxidant and anti-inflammatory actions and prevents oxaliplatin-induced mechanical and thermal allodynia.
Recalde MD; Miguel CA; Noya-Riobó MV; González SL; Villar MJ; Coronel MF
Brain Res; 2020 Dec; 1748():147079. PubMed ID: 32866545
[TBL] [Abstract][Full Text] [Related]
6. Spinal neuroimmune activation is independent of T-cell infiltration and attenuated by A3 adenosine receptor agonists in a model of oxaliplatin-induced peripheral neuropathy.
Janes K; Wahlman C; Little JW; Doyle T; Tosh DK; Jacobson KA; Salvemini D
Brain Behav Immun; 2015 Feb; 44():91-9. PubMed ID: 25220279
[TBL] [Abstract][Full Text] [Related]
7. Target enzymes in oxaliplatin-induced peripheral neuropathy in Swiss mice: A new acetylcholinesterase inhibitor as therapeutic strategy.
da Motta KP; Santos BF; Domingues NLC; Luchese C; Wilhelm EA
Chem Biol Interact; 2022 Jan; 352():109772. PubMed ID: 34896366
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of Immune and Neuroinflammatory Changes Associated with Chemotherapy-Induced Peripheral Neuropathy.
Makker PG; Duffy SS; Lees JG; Perera CJ; Tonkin RS; Butovsky O; Park SB; Goldstein D; Moalem-Taylor G
PLoS One; 2017; 12(1):e0170814. PubMed ID: 28125674
[TBL] [Abstract][Full Text] [Related]
9. Mitotherapy prevents peripheral neuropathy induced by oxaliplatin in mice.
Maia JRLCB; Machado LKA; Fernandes GG; Vitorino LC; Antônio LS; Araújo SMB; Colodeti LC; Fontes-Dantas FL; Zeidler JD; Saraiva GN; Da Poian AT; Figueiredo CP; Passos GF; da Costa R
Neuropharmacology; 2024 Mar; 245():109828. PubMed ID: 38158014
[TBL] [Abstract][Full Text] [Related]
10. Anti-allodynic and anti-inflammatory effects of 17α-hydroxyprogesterone caproate in oxaliplatin-induced peripheral neuropathy.
Miguel CA; Raggio MC; Villar MJ; Gonzalez SL; Coronel MF
J Peripher Nerv Syst; 2019 Mar; 24(1):100-110. PubMed ID: 30680838
[TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy.
Joseph EK; Chen X; Bogen O; Levine JD
J Pain; 2008 May; 9(5):463-72. PubMed ID: 18359667
[TBL] [Abstract][Full Text] [Related]
12. Nanoliposomal oxaliplatin ameliorates chemotherapy-induced neuropathy.
Alaei M; Moetamani-Ahmadi M; Mahaki H; Fiuji H; Maftooh M; Hassanian SM; Khazaei M; Shahri AP; Ferns GA; Frozanfar F; Tanzadehpanah H; Avan A
Neurosci Lett; 2023 Aug; 812():137367. PubMed ID: 37419304
[TBL] [Abstract][Full Text] [Related]
13. Curcumin relieves oxaliplatin-induced neuropathic pain via reducing inflammation and activating antioxidant response.
Zhang MW; Sun X; Xu YW; Meng W; Tang Q; Gao H; Liu L; Chen SH
Cell Biol Int; 2024 Jun; 48(6):872-882. PubMed ID: 38480956
[TBL] [Abstract][Full Text] [Related]
14. Prevention of Chemotherapy-Induced Peripheral Neuropathy by Inhibiting C-X-C Motif Chemokine Receptor 2.
Cho HS; Choi YI; Park SU; Han YS; Kwon J; Jung SJ
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768178
[TBL] [Abstract][Full Text] [Related]
15. Oxaliplatin-induced neuropathy: oxidative stress as pathological mechanism. Protective effect of silibinin.
Di Cesare Mannelli L; Zanardelli M; Failli P; Ghelardini C
J Pain; 2012 Mar; 13(3):276-84. PubMed ID: 22325298
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells reduce the oxaliplatin-induced sensory neuropathy through the reestablishment of redox homeostasis in the spinal cord.
Dos Santos GGL; Oliveira ALL; Santos DS; do Espírito Santo RF; Silva DN; Juiz PJL; Soares MBP; Villarreal CF
Life Sci; 2021 Jan; 265():118755. PubMed ID: 33189826
[TBL] [Abstract][Full Text] [Related]
17. Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents.
Ushio S; Egashira N; Sada H; Kawashiri T; Shirahama M; Masuguchi K; Oishi R
Eur J Cancer; 2012 Jun; 48(9):1407-13. PubMed ID: 21907570
[TBL] [Abstract][Full Text] [Related]
18. The antioxidant effects of the flavonoids rutin and quercetin inhibit oxaliplatin-induced chronic painful peripheral neuropathy.
Azevedo MI; Pereira AF; Nogueira RB; Rolim FE; Brito GA; Wong DV; Lima-Júnior RC; de Albuquerque Ribeiro R; Vale ML
Mol Pain; 2013 Oct; 9():53. PubMed ID: 24152430
[TBL] [Abstract][Full Text] [Related]
19. Orally active Epac inhibitor reverses mechanical allodynia and loss of intraepidermal nerve fibers in a mouse model of chemotherapy-induced peripheral neuropathy.
Singhmar P; Huo X; Li Y; Dougherty PM; Mei F; Cheng X; Heijnen CJ; Kavelaars A
Pain; 2018 May; 159(5):884-893. PubMed ID: 29369966
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine Stress Axis-Dependence of Duloxetine Analgesia (Anti-Hyperalgesia) in Chemotherapy-Induced Peripheral Neuropathy.
Staurengo-Ferrari L; Bonet IJM; Araldi D; Green PG; Levine JD
J Neurosci; 2022 Jan; 42(3):405-415. PubMed ID: 34880120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
